Researchers at Wake Forest University are developing a nanotech process which could potentially speed the search for new anti-cancer drugs. The "Lab-on-Bead" process involves using tiny plastic beads, each carrying a different chemical, to identify which chemicals display cancer-fighting properties. Technologies currently in use only allow researchers to screen several hundred thousand drug candidates per day, while this technique is expected to allow researchers the ability to screen more than a billion possible drug candidates in that time.

Wake Forest is conducting the project in partnership with the University of Waterloo in Ontario, Canada, with funding from the North Carolina Biotechnology Center.

- read The Business Journal for more [1]

Related Articles:
Cancer drug reverses damage from genetic disorder [2]
Screening method IDs host of HIV drug targets [3]
Biovest wants accelerated approval for anti-cancer vax [4]
Cancer groups compete for research funds [5]